Amedeo Smart

Free Medical Literature Service


 

Amedeo

Colorectal Neoplasms

  Free Subscription

15.07.2024

1 Ann Oncol
1 Ann Surg
11 Ann Surg Oncol
3 BMC Cancer
2 BMC Gastroenterol
1 Br J Cancer
1 Cancer Lett
2 Eur J Surg Oncol
1 Gut
3 Int J Cancer
1 Int J Colorectal Dis
1 J Clin Oncol
1 J Natl Cancer Inst
2 N Engl J Med
1 Oncology
4 PLoS One
1 Proc Natl Acad Sci U S A
2 World J Surg



    Ann Oncol

  1. BIONDO S, Frago R, Kreisler E
    Primary tumor resection for asymptomatic colorectal cancer with unresectable metastasis: the end of the dilemma.
    Ann Oncol. 2024 Jul 3:S0923-7534(24)00767-1. doi: 10.1016/j.annonc.2024.
    >> Share


    Ann Surg

  2. MCINTYRE SM, Soares KC, Chou JF, D'Amico F, et al
    Surgical Margin of Resected Colorectal Liver Metastases: How Accurate Is Surgeon Prediction?
    Ann Surg. 2024;280:311-316.
    >> Share


    Ann Surg Oncol

  3. ROXBURGH CS
    Time to Change Strategy in Non-metastatic Locally Advanced Mismatch Repair-Deficient Colon Cancer.
    Ann Surg Oncol. 2024 Jul 11. doi: 10.1245/s10434-024-15780.
    >> Share

  4. STEFFENS D, Solomon MJ, Jack S, West MA, et al
    ASO Author Reflections: Improving Postoperative Outcomes in Colorectal Cancer Surgery: Where are We with Prehabilitation?
    Ann Surg Oncol. 2024 Jul 11. doi: 10.1245/s10434-024-15835.
    >> Share

  5. SMITH HG, Schlesinger NH, Chiranth D, Qvortrup C, et al
    ASO Visual Abstract: The Association of Mismatch Repair Status with Microscopically Positive (R1) Margins in Stage III Colorectal Cancer-A Retrospective Cohort Study.
    Ann Surg Oncol. 2024 Jul 10. doi: 10.1245/s10434-024-15747.
    >> Share

  6. CHEN M, Deng S, Cao Y, Wang J, et al
    Mitochondrial DNA Copy Number as a Biomarker for Guiding Adjuvant Chemotherapy in Stages II and III Colorectal Cancer Patients with Mismatch Repair Deficiency: Seeking Benefits and Avoiding Harms.
    Ann Surg Oncol. 2024 Jul 10. doi: 10.1245/s10434-024-15759.
    >> Share

  7. LIN X, Haiyang Z
    Patient-Reported Outcomes in Chinese Patients with Locally Advanced or Recurrent Colorectal Cancer After Pelvic Exenteration.
    Ann Surg Oncol. 2024 Jul 9. doi: 10.1245/s10434-024-15722.
    >> Share

  8. LIN X, Haiyang Z
    ASO Author Reflections: Pelvic Exenteration for Chinese Patients with Locally Advanced or Recurrent Colorectal Cancer: A Report of 122 Cases.
    Ann Surg Oncol. 2024 Jul 8. doi: 10.1245/s10434-024-15782.
    >> Share

  9. AYABE RI, Beaty K, Newhook TE, Cao HST, et al
    Incomplete Cytoreduction and Need for Major Hepatectomy Predict Shorter Survival in Patients Undergoing Combined Cytoreductive Surgery and Hepatectomy for Metastatic Colorectal Cancer.
    Ann Surg Oncol. 2024 Jul 6. doi: 10.1245/s10434-024-15694.
    >> Share

  10. WILLIAMS H, Thompson HM, Lee C, Rangnekar A, et al
    ASO Visual Abstract: Assessing Endoscopic Response in Locally Advanced Rectal Cancer Treated with Total Neoadjuvant Therapy: Development and Validation of a Highly Accurate Convolutional Neural Network.
    Ann Surg Oncol. 2024;31:5002-5003.
    >> Share

  11. NABATA KJ, Rai S, Zhao D, MacNeill AJ, et al
    ASO Visual Abstract: Negative Pressure Wound Therapy to Reduce Surgical Site Infections After CRS/HIPEC.
    Ann Surg Oncol. 2024;31:5219.
    >> Share

  12. CIFTCI Y, Radomski SN, Johnston FM, Greer JB, et al
    ASO Author Reflections: One Size Does Not Fit All-Enhanced Recovery After Surgery in CRS-HIPEC.
    Ann Surg Oncol. 2024;31:5400-5401.
    >> Share

  13. LAROCHE S, Scatton O, Charlotte F, Bachet JB, et al
    ASO Visual Abstract: Prognosis of a Heterogeneous TRG Pathological Response to Neoadjuvant Chemotherapy in Patients Who Undergo Resection for Colorectal Liver Metastases.
    Ann Surg Oncol. 2024;31:5217-5218.
    >> Share


    BMC Cancer

  14. MATBOLI M, Hossam N, Farag D, Hassan M, et al
    miRNAs: possible regulators of toll like receptors and inflammatory tumor microenvironment in colorectal cancer.
    BMC Cancer. 2024;24:824.
    >> Share

  15. AYNALEM ZB, Adal AB, Ayele TF, Bayeh GM, et al
    Mortality rate and predictors of colorectal cancer patients in Ethiopia: a systematic review and meta-analysis.
    BMC Cancer. 2024;24:821.
    >> Share

  16. TALBOT A, Jebb SA, Foster C, Realpe AX, et al
    Participants' perspectives of being recruited into a randomised trial of a weight loss intervention before colorectal cancer surgery: a qualitative interview study.
    BMC Cancer. 2024;24:802.
    >> Share


    BMC Gastroenterol

  17. HE W, Yang Y, Liu Q, Luo D, et al
    Conditional survival and the prognostic value of serum carcinoembryonic antigen level in oldest old with colorectal cancer.
    BMC Gastroenterol. 2024;24:220.
    >> Share

  18. LI Y, Ran D, Basnet S, Zhang B, et al
    The expression and clinical significance of CFAP65 in colon cancer.
    BMC Gastroenterol. 2024;24:222.
    >> Share


    Br J Cancer

  19. MASUI H, Kawada K, Itatani Y, Hirai H, et al
    Synergistic antitumor activity by dual blockade of CCR1 and CXCR2 expressed on myeloid cells within the tumor microenvironment.
    Br J Cancer. 2024;131:63-76.
    >> Share


    Cancer Lett

  20. ZHU N, Ding Y, Mi M, Yang J, et al
    Loss-of-function mutation of REV1 (p.R704Q) mediates cetuximab primary resistance by activating autophagy in RAS-wild type metastatic colorectal cancer.
    Cancer Lett. 2024 Jul 3:217103. doi: 10.1016/j.canlet.2024.217103.
    >> Share


    Eur J Surg Oncol

  21. MAKI H, Vauthey JN, You YN
    Reply to: Critical Appraisal of multidisciplinary treatment outcomes in young-onset colorectal cancer with synchronous liver metastases: A retrospective analysis and methodological Considerations.
    Eur J Surg Oncol. 2024 Jun 29:108520. doi: 10.1016/j.ejso.2024.108520.
    >> Share

  22. SU Y, Li Y, Zhang H, Yang W, et al
    Machine learning model for prediction of permanent stoma after anterior resection of rectal cancer: A multicenter study.
    Eur J Surg Oncol. 2024;50:108386.
    >> Share


    Gut

  23. MAO X, Cheung KS, Tan JT, Mak LY, et al
    Optimal glycaemic control and the reduced risk of colorectal adenoma and cancer in patients with diabetes: a population-based cohort study.
    Gut. 2024;73:1313-1320.
    >> Share


    Int J Cancer

  24. NESIC M, Rasmussen MH, Henriksen TV, Demuth C, et al
    Beyond basics: Key mutation selection features for successful tumor-informed ctDNA detection.
    Int J Cancer. 2024;155:925-933.
    >> Share

  25. NISHIHARA K, Nakano S, Yamaji T, Goto A, et al
    Height, body mass index, physical activity, and risk of colorectal cancer in relation to expression of insulin receptor: The Japan Public Health Center-based Prospective Study.
    Int J Cancer. 2024 Jul 6. doi: 10.1002/ijc.35075.
    >> Share

  26. RAFIQUE A, Ali I, Kim S, Farooq A, et al
    Toll-like receptor 13-mediated signaling protects against the development of colon cancer.
    Int J Cancer. 2024 Jul 11. doi: 10.1002/ijc.35089.
    >> Share


    Int J Colorectal Dis

  27. HUANG F, Jiang S, Wei R, Xiao T, et al
    Association of resection margin distance with anastomotic recurrence in stage I-III colon cancer: data from the National Colorectal Cancer Cohort (NCRCC) study in China.
    Int J Colorectal Dis. 2024;39:105.
    >> Share


    J Clin Oncol

  28. JAIN A, Lau NS
    Liver Transplantation in Colorectal Cancer With Unresectable Liver Metastases: Disease Biology Cannot Be Ignored.
    J Clin Oncol. 2024 Jul 8:JCO2400619. doi: 10.1200/JCO.24.00619.
    >> Share


    J Natl Cancer Inst

  29. GOPALANI SV, Saraiya M, Huang B, Tucker TC, et al
    Population-level incidence of HPV-positive oropharyngeal, cervical, and anal cancers by smoking status.
    J Natl Cancer Inst. 2024 Mar 1:djae054. doi: 10.1093.
    >> Share


    N Engl J Med

  30. FAKIH MG, Chao J
    Sotorasib in KRAS-Mutated Colorectal Cancer. Reply.
    N Engl J Med. 2024;391:187.
    >> Share

  31. FOJO T
    Sotorasib in KRAS-Mutated Colorectal Cancer.
    N Engl J Med. 2024;391:186-187.
    >> Share


    Oncology

  32. ROMERO ZOGHBI SE, Martin Martin M, Garcia JC, Valero M, et al
    Total Neoadjuvant Therapy Approach for the Treatment of Locally Advanced Rectal Cancer: Where Do We Stand?
    Oncology. 2024;102:646-658.
    >> Share


    PLoS One

  33. LOVALL C, Mjelde LME, Eide LSP, Reime MH, et al
    Patients' experiences of living with low anterior resection syndrome three to six months after colorectal cancer surgery: A phenomenological study.
    PLoS One. 2024;19:e0305212.
    >> Share

  34. ZHANG X, Li W, Wang X, Lin J, et al
    Effectiveness of D-dimer in predicting distant metastasis in colorectal cancer.
    PLoS One. 2024;19:e0306909.
    >> Share

  35. LIN L, Fang Y, Huang F, Zhang X, et al
    Discharge teaching quality positively predicts quality of life in colorectal cancer patients with temporary enterostomy: The mediating role of readiness for hospital discharge and stoma self-efficacy.
    PLoS One. 2024;19:e0306981.
    >> Share

  36. HUANG X, Wang L, Jiang S, Xu L, et al
    DHAFormer: Dual-channel hybrid attention network with transformer for polyp segmentation.
    PLoS One. 2024;19:e0306596.
    >> Share


    Proc Natl Acad Sci U S A

  37. BORTEL P, Hagn G, Skos L, Bileck A, et al
    Memory effects of prior subculture may impact the quality of multiomic perturbation profiles.
    Proc Natl Acad Sci U S A. 2024;121:e2313851121.
    >> Share


    World J Surg

  38. FAZELI AR, Tadbir Vajargah K, Fazeli MS, Behboudi B, et al
    Gross morphologic features of surgical specimen in rectal cancer patients with pathological complete response following neoadjuvant chemoradiotherapy: A cross-sectional study.
    World J Surg. 2024;48:1759-1766.
    >> Share

  39. PYO DH, Yun SH, Lee WY
    A prospective single-arm clinical trial to assess the safety and efficacy of monofilament polydioxanone barbed suture, MONOFIX((R)), on abdominal fascial closure.
    World J Surg. 2024;48:1674-1680.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016